Cerebral hyperperfusion syndrome (CHS) is a rare complication following cerebral revascularization. It presents with ipsilateral headache, seizures, and intracerebral hemorrhage. It has mostly been described following extracranial carotid endarterectomy and stenting and it is very unusual after intracranial stenting. A 71-year-old man with a stuttering stroke was taken up for a cerebral angiogram (digital subtraction angiography), which showed a dissection of the distal left middle cerebral artery. This was recanalized with a solitaire AB stent. After 12 h, the patient developed a right hemiplegia and aphasia. Computed tomography brain showed two discrete intracerebral hematomas in the left hemisphere. This is the first reported case of CHS following intracranial stenting from India.
Liu AY, Do HM, Albers GW, Lopez JR, Steinberg GK, Marks MP. Hyperperfusion sydrome with hemorrhage after angioplasty for middle cerebral artery stenosis. AJNR Am J Neuroradiol 2001;22:1597-601.
Rezende MT, Spelle L, Mounayer C, Piotin M, Abud DG, Moret J. Hyperperfusion syndrome after stenting for intracranial vertebral stenosis. Stroke 2006;37:e12-4.
Gralla J, Rennie AT, Squire W, Rothwell PM, Kuker W. Fatal hemorrhage after attempted treatment of a basilar artery stenosis. Case report. J Neurosurg 2009;111:102-4.
Zhang R, Zhou G, Xu G, Liu X. Posterior circulation hyperperfusion syndrome after bilateral vertebral artery intracranial stenting. Ann Vasc Surg 2009;23:686.e1-5.
Meyers PM, Phatouros CC, Higashida RT. Hyperperfusion syndrome after intracranial angioplasty and stent placement. Stroke 2006;37:2210-1.
Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): The final results of a randomised trial. Lancet 2014;383:333-41.
Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A, et al. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: The VISSIT randomized clinical trial. JAMA 2015;313:1240-8.
Cheng L, Jiao L, Gao P, Song G, Chen S, Wang X, et al. Risk factors associated with in-hospital serious adverse events after stenting of severe symptomatic intracranial stenosis. Clin Neurol Neurosurg 2016;147:59-63.
Adhiyaman V, Alexander S. Cerebral hyperperfusion syndrome following carotid endarterectomy. QJM 2007;100:239-44.
Maltezos CK, Papanas N, Papas TT, Georgiadis GS, Dragoumanis CK, Marakis J, et al. Changes in blood flow of anterior and middle cerebral arteries following carotid endarterectomy: A transcranial Doppler study. Vasc Endovascular Surg 2007;41:389-96.
Pennekamp CW, Immink RV, den Ruijter HM, Kappelle LJ, Ferrier CM, Bots ML, et al. Near-infrared spectroscopy can predict the onset of cerebral hyperperfusion syndrome after carotid endarterectomy. Cerebrovasc Dis 2012;34:314-21.
Matsumoto S, Nakahara I, Higashi T, Iwamuro Y, Watanabe Y, Takahashi K, et al. Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome. Neurology 2009;72:1512-8.